Treatment of Brucella Endocarditis with Sacroileitis
Introduction to Brucella Endocarditis
- The European Society of Cardiology recommends aggressive combination antimicrobial therapy with doxycycline, rifampin, cotrimoxazole, and streptomycin for at least 3-6 months, along with consideration for early cardiac surgery for Brucella endocarditis with sacroileitis 1
Antimicrobial Treatment Regimen
- The European Society of Cardiology recommends doxycycline 200 mg/24 hours orally for confirmed Brucella endocarditis with sacroileitis 1, 3, 4
- The European Society of Cardiology recommends cotrimoxazole 960 mg/12 hours orally for confirmed Brucella endocarditis with sacroileitis 1, 3, 4
- The European Society of Cardiology recommends rifampin 300-600 mg/24 hours orally for confirmed Brucella endocarditis with sacroileitis 1, 3, 4
- The European Society of Cardiology recommends a treatment duration of at least 3-6 months for confirmed Brucella endocarditis with sacroileitis 1, 3, 4
- Treatment success is defined as antibody titer falling below 1:60, as demonstrated by the European Society of Cardiology 1, 3, 4, 5
Surgical Considerations
- Approximately 50% of endocarditis patients require surgical intervention, according to the American Heart Association 2
- Indications for surgery include heart failure due to valve dysfunction, uncontrolled infection with abscess formation, persistent positive blood cultures despite appropriate therapy, and prevention of systemic embolism, as recommended by the American Heart Association 2
Multidisciplinary Management
- Consultation with an infectious disease specialist from the Endocarditis Team is mandatory for this rare and severe presentation, as recommended by the European Society of Cardiology 1, 6, 4, 2
- These cases should be discussed by the Endocarditis Team, which includes infectious disease specialists, cardiologists, cardiac surgeons, and microbiologists, as recommended by the American Heart Association 2
Monitoring and Follow-up
- Serial Brucella agglutination titers should be followed to document treatment response, with success defined as titers <1:60, as recommended by the European Society of Cardiology 1, 5
Critical Pitfalls to Avoid
- Do not use trimethoprim alone, as it is not active against certain endocarditis pathogens; cotrimoxazole (which contains both trimethoprim and sulfamethoxazole) is required, as recommended by the European Society of Cardiology 1, 3
- Ensure adequate duration of therapy (minimum 3-6 months) to prevent relapse, as shorter courses are associated with treatment failure, as recommended by the European Society of Cardiology 1